Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation
Pediatric Blood & Cancer · 2025-04 · 72 (4)
DOI: 10.1002/pbc.31545 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 16.01.2025. Verfasst von Priya Mahajan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Practice Guidelines as Topic, Thyroidectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Differentiated thyroid carcinoma (DTC) is the most common pediatric thyroid malignancy, with papillary thyroid carcinoma (PTC) representing 90% of the cases. In 2015, the American Thyroid Association (ATA) developed management guidelines for pediatric DTC. Procedure Patients less than 21 years of age diagnosed with DTC between 2000 and 2015 at Texas Children's Hospital, Seattle Children's Hospital, Children's Healthcare of Atlanta, Children's Hospital Colorado, and Nationwide Children's Hospital were retrospectively analyzed to evaluate treatment practices before the implementation of the ATA guidelines.
Results
We included 216 pediatric patients with DTC. A majority were female (76%) with a median age at diagnosis of 14.8 years. Neck swelling (56%) and palpable nodules (49%) were common presenting symptoms. Diagnostic evaluations typically included thyroid ultrasound, with common features being microcalcifications (47.7%) and hypoechogenicity (39.0%). Fine‐needle aspiration cytology confirmed diagnosis in 50.5%. The majority of patients underwent total thyroidectomy (78.7%) and lymph node dissection (75.5%). ATA risk stratification was low, intermediate, and high risk in 111 (51.4%), 29 (13.4%), and 76 patients (35.2%), respectively. Upfront radioactive iodine (RAI) was administered in 83%. At 1‐year follow‐up, 46% were disease‐free (66% low risk, 59% intermediate risk, and 13% high risk). The 5‐year progression‐free survival for low, intermediate, and high risk were 86%, 53%, and 43%, respectively. The disease‐related overall survival was 100%.
Conclusions
Prior to the introduction of the ATA guidelines, a majority of patients underwent total thyroidectomy with lymph node dissection followed by RAI. Selective use of RAI for low‐risk disease as recommended in the current guidelines may be appropriate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
- Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
- Section of Hematology/Oncology, Department of Pediatrics, Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts, USA.
- Division of Endocrinology, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
- Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Division of Endocrinology, Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
ORCID-Profile: Jennifer H Aldrink, Douglas S Hawkins, Thomas A Olson
Zitieren
APA
Mahajan, P., May, S. B., Shekar, M., Werny, D., Patterson, B. C., Chan, C. M., Aldrink, J. H., Horvath, K. Z., Hawkins, D. S., Olson, T. A., & Venkatramani, R. (2025). Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation. Pediatric Blood & Cancer, 72(4). https://doi.org/10.1002/pbc.31545
Vancouver
Mahajan P, May SB, Shekar M, Werny D, Patterson BC, Chan CM, et al. Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation. Pediatric Blood & Cancer. 2025;72(4). doi:10.1002/pbc.31545
BibTeX
@article{Mahajan2025,
author = {Mahajan, Priya and May, Sarah Beth and Shekar, Meghan and Werny, David and Patterson, Briana C and Chan, Christine M and Aldrink, Jennifer H and Horvath, Kyle Z and Hawkins, Douglas S and Olson, Thomas A and Venkatramani, Rajkumar},
title = {Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation},
journal = {Pediatric Blood & Cancer},
year = {2025},
volume = {72},
number = {4},
doi = {10.1002/pbc.31545}
}
EUVIMED